

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitotic metaphase plate congression (GO:0007080) | 4.98736975 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 4.79098600 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 4.79098600 |
| 4 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 4.63031160 |
| 5 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 4.63031160 |
| 6 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 4.63031160 |
| 7 | DNA replication checkpoint (GO:0000076) | 4.59408558 |
| 8 | regulation of sister chromatid cohesion (GO:0007063) | 4.58277450 |
| 9 | maturation of 5.8S rRNA (GO:0000460) | 4.43219727 |
| 10 | positive regulation of chromosome segregation (GO:0051984) | 4.41916784 |
| 11 | DNA deamination (GO:0045006) | 4.25176870 |
| 12 | CENP-A containing nucleosome assembly (GO:0034080) | 4.25081892 |
| 13 | chromatin remodeling at centromere (GO:0031055) | 4.18968520 |
| 14 | protein deneddylation (GO:0000338) | 4.18359147 |
| 15 | proteasome assembly (GO:0043248) | 4.16119261 |
| 16 | DNA replication initiation (GO:0006270) | 4.15697421 |
| 17 | non-recombinational repair (GO:0000726) | 4.13655791 |
| 18 | double-strand break repair via nonhomologous end joining (GO:0006303) | 4.13655791 |
| 19 | metaphase plate congression (GO:0051310) | 4.12925916 |
| 20 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.05756854 |
| 21 | rRNA modification (GO:0000154) | 3.95832789 |
| 22 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.93359105 |
| 23 | protein maturation by protein folding (GO:0022417) | 3.92533521 |
| 24 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.91887100 |
| 25 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.91714980 |
| 26 | maturation of SSU-rRNA (GO:0030490) | 3.85428640 |
| 27 | DNA strand elongation (GO:0022616) | 3.85202998 |
| 28 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.83566266 |
| 29 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.79668756 |
| 30 | termination of RNA polymerase III transcription (GO:0006386) | 3.79668756 |
| 31 | DNA replication-independent nucleosome organization (GO:0034724) | 3.79378398 |
| 32 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.79378398 |
| 33 | protein K6-linked ubiquitination (GO:0085020) | 3.75196951 |
| 34 | cullin deneddylation (GO:0010388) | 3.75137796 |
| 35 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.72530505 |
| 36 | establishment of chromosome localization (GO:0051303) | 3.72120872 |
| 37 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.70823392 |
| 38 | purine nucleobase biosynthetic process (GO:0009113) | 3.67974316 |
| 39 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.67390151 |
| 40 | telomere maintenance via recombination (GO:0000722) | 3.65006961 |
| 41 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.64746760 |
| 42 | nucleobase biosynthetic process (GO:0046112) | 3.63594892 |
| 43 | kinetochore assembly (GO:0051382) | 3.62265166 |
| 44 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.61019295 |
| 45 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.61019295 |
| 46 | tRNA aminoacylation for protein translation (GO:0006418) | 3.55436154 |
| 47 | mitotic sister chromatid segregation (GO:0000070) | 3.54830722 |
| 48 | tRNA aminoacylation (GO:0043039) | 3.51648282 |
| 49 | amino acid activation (GO:0043038) | 3.51648282 |
| 50 | proline biosynthetic process (GO:0006561) | 3.51557590 |
| 51 | histone exchange (GO:0043486) | 3.51190437 |
| 52 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.50708748 |
| 53 | * 7-methylguanosine mRNA capping (GO:0006370) | 3.50055083 |
| 54 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.48379562 |
| 55 | chaperone-mediated protein transport (GO:0072321) | 3.47317558 |
| 56 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.43684098 |
| 57 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.43684098 |
| 58 | spliceosomal snRNP assembly (GO:0000387) | 3.43215710 |
| 59 | mitochondrial RNA metabolic process (GO:0000959) | 3.40458965 |
| 60 | * RNA capping (GO:0036260) | 3.39946843 |
| 61 | * 7-methylguanosine RNA capping (GO:0009452) | 3.39946843 |
| 62 | regulation of translational fidelity (GO:0006450) | 3.39688584 |
| 63 | protein localization to kinetochore (GO:0034501) | 3.39609912 |
| 64 | kinetochore organization (GO:0051383) | 3.38965747 |
| 65 | * transcription-coupled nucleotide-excision repair (GO:0006283) | 3.38688997 |
| 66 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.38364516 |
| 67 | mitotic recombination (GO:0006312) | 3.37983681 |
| 68 | rRNA methylation (GO:0031167) | 3.37526040 |
| 69 | negative regulation of ligase activity (GO:0051352) | 3.36813226 |
| 70 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.36813226 |
| 71 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.36454365 |
| 72 | formation of translation preinitiation complex (GO:0001731) | 3.36151312 |
| 73 | regulation of translational termination (GO:0006449) | 3.35295035 |
| 74 | regulation of ligase activity (GO:0051340) | 3.35115466 |
| 75 | ribosome biogenesis (GO:0042254) | 3.34377103 |
| 76 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.32893176 |
| 77 | ribosome assembly (GO:0042255) | 3.30822454 |
| 78 | L-serine metabolic process (GO:0006563) | 3.30052658 |
| 79 | mitotic nuclear envelope disassembly (GO:0007077) | 3.29369594 |
| 80 | ribosomal large subunit biogenesis (GO:0042273) | 3.27369293 |
| 81 | spindle checkpoint (GO:0031577) | 3.26338986 |
| 82 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.25191465 |
| 83 | regulation of spindle organization (GO:0090224) | 3.24951425 |
| 84 | rRNA processing (GO:0006364) | 3.24497725 |
| 85 | telomere maintenance via telomere lengthening (GO:0010833) | 3.23842682 |
| 86 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.22435066 |
| 87 | mitotic chromosome condensation (GO:0007076) | 3.21242862 |
| 88 | establishment of viral latency (GO:0019043) | 3.20632396 |
| 89 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.20631036 |
| 90 | positive regulation of ligase activity (GO:0051351) | 3.19934085 |
| 91 | regulation of mitochondrial translation (GO:0070129) | 3.19197309 |
| 92 | spliceosomal complex assembly (GO:0000245) | 3.19192466 |
| 93 | protein localization to chromosome, centromeric region (GO:0071459) | 3.18067461 |
| 94 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.17351746 |
| 95 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.16887892 |
| 96 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.16243927 |
| 97 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.16145144 |
| 98 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.15849069 |
| 99 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.13743360 |
| 100 | establishment of integrated proviral latency (GO:0075713) | 3.13723145 |
| 101 | metallo-sulfur cluster assembly (GO:0031163) | 3.12898994 |
| 102 | iron-sulfur cluster assembly (GO:0016226) | 3.12898994 |
| 103 | coenzyme A biosynthetic process (GO:0015937) | 3.12322056 |
| 104 | rRNA metabolic process (GO:0016072) | 3.12175344 |
| 105 | prenylation (GO:0097354) | 3.11788291 |
| 106 | protein prenylation (GO:0018342) | 3.11788291 |
| 107 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.11435561 |
| 108 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.11435561 |
| 109 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.11435561 |
| 110 | negative regulation of sister chromatid segregation (GO:0033046) | 3.11435561 |
| 111 | negative regulation of chromosome segregation (GO:0051985) | 3.10626881 |
| 112 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.08644281 |
| 113 | mitotic spindle checkpoint (GO:0071174) | 3.07395276 |
| 114 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.07267013 |
| 115 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.07150573 |
| 116 | cell cycle G1/S phase transition (GO:0044843) | 3.07150573 |
| 117 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.06991253 |
| 118 | IMP biosynthetic process (GO:0006188) | 3.06628404 |
| 119 | protein targeting to mitochondrion (GO:0006626) | 3.06367613 |
| 120 | mitotic spindle assembly checkpoint (GO:0007094) | 3.04153395 |
| 121 | ribosomal small subunit assembly (GO:0000028) | 3.03998698 |
| 122 | L-methionine salvage (GO:0071267) | 3.03819652 |
| 123 | L-methionine biosynthetic process (GO:0071265) | 3.03819652 |
| 124 | amino acid salvage (GO:0043102) | 3.03819652 |
| 125 | transcription from RNA polymerase I promoter (GO:0006360) | 3.03507585 |
| 126 | tricarboxylic acid cycle (GO:0006099) | 3.02184072 |
| 127 | * transcription elongation from RNA polymerase II promoter (GO:0006368) | 3.01557735 |
| 128 | DNA unwinding involved in DNA replication (GO:0006268) | 3.01183949 |
| 129 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.00845694 |
| 130 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.00845694 |
| 131 | membrane disassembly (GO:0030397) | 3.00798222 |
| 132 | nuclear envelope disassembly (GO:0051081) | 3.00798222 |
| 133 | ribosomal small subunit biogenesis (GO:0042274) | 3.00062233 |
| 134 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.99854732 |
| 135 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.99854732 |
| 136 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.99854732 |
| 137 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.99758088 |
| 138 | negative regulation of protein ubiquitination (GO:0031397) | 2.97156392 |
| 139 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.96447530 |
| 140 | pseudouridine synthesis (GO:0001522) | 2.96198529 |
| 141 | GDP-mannose metabolic process (GO:0019673) | 2.94043005 |
| 142 | positive regulation of cell cycle arrest (GO:0071158) | 2.91825687 |
| 143 | COPII vesicle coating (GO:0048208) | 2.91478790 |
| 144 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.86168495 |
| 145 | regulation of cellular amine metabolic process (GO:0033238) | 2.85162606 |
| 146 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.84847944 |
| 147 | establishment of protein localization to mitochondrion (GO:0072655) | 2.79342964 |
| 148 | peptidyl-lysine dimethylation (GO:0018027) | 2.78388886 |
| 149 | translation (GO:0006412) | 2.71099523 |
| 150 | negative regulation of Ras GTPase activity (GO:0034261) | 2.71013580 |
| 151 | IMP metabolic process (GO:0046040) | 2.70303029 |
| 152 | eosinophil chemotaxis (GO:0048245) | 2.69909287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.44337093 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.30963794 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.27926589 |
| 4 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.74874119 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.69111113 |
| 6 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.64663773 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.47412241 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.46247141 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.37242056 |
| 10 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.31496365 |
| 11 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.23994878 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.22014125 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.04805771 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.94400059 |
| 15 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.94093222 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.91030511 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.83943391 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.80889929 |
| 19 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.66892811 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.52172348 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.48497319 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.44397498 |
| 23 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.42308024 |
| 24 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.35899083 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.32877615 |
| 26 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.32049750 |
| 27 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.28721086 |
| 28 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.19878273 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.12497819 |
| 30 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.08340922 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.04056149 |
| 32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.03876591 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.97447296 |
| 34 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.97114797 |
| 35 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.96052414 |
| 36 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.95425538 |
| 37 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.93936588 |
| 38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.91794539 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.89815760 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87272862 |
| 41 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.78082817 |
| 42 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.77564651 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.77323718 |
| 44 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.74895352 |
| 45 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.70397997 |
| 46 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67839175 |
| 47 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67571987 |
| 48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.58128547 |
| 49 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.57254926 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.55874082 |
| 51 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54215382 |
| 52 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53464377 |
| 53 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.52396524 |
| 54 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52364917 |
| 55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49197104 |
| 56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45158056 |
| 57 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.42474793 |
| 58 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41322685 |
| 59 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.39897434 |
| 60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.39372303 |
| 61 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37277698 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33254375 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.32824152 |
| 64 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.32410925 |
| 65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31589228 |
| 66 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.29087343 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25316015 |
| 68 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.21712908 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21515011 |
| 70 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.20659172 |
| 71 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.18798112 |
| 72 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.18275470 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17997147 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16614861 |
| 75 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.15246922 |
| 76 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14627119 |
| 77 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.12281560 |
| 78 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11958963 |
| 79 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11642060 |
| 80 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10715884 |
| 81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.10697450 |
| 82 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09425825 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08296101 |
| 84 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06610953 |
| 85 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06112934 |
| 86 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05937790 |
| 87 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05225527 |
| 88 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.03639815 |
| 89 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.03589755 |
| 90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02892685 |
| 91 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00706419 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99520311 |
| 93 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98890199 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97887322 |
| 95 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.95670560 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95111400 |
| 97 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95041046 |
| 98 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.94738253 |
| 99 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.94733315 |
| 100 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.93365190 |
| 101 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.92607600 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91786677 |
| 103 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90632558 |
| 104 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.90498526 |
| 105 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.90390297 |
| 106 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.90339678 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87720689 |
| 108 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.87350573 |
| 109 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.84908361 |
| 110 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.84666650 |
| 111 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84055301 |
| 112 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.82719477 |
| 113 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.82196648 |
| 114 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.81354816 |
| 115 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80791479 |
| 116 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.80272836 |
| 117 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.78655631 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.77451523 |
| 119 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.77446098 |
| 120 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77041847 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.75848139 |
| 122 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.71176929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.83755694 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.54130720 |
| 3 | MP0003111_abnormal_nucleus_morphology | 4.43357834 |
| 4 | MP0010094_abnormal_chromosome_stability | 4.28852680 |
| 5 | MP0003077_abnormal_cell_cycle | 3.90219433 |
| 6 | MP0003718_maternal_effect | 3.52113929 |
| 7 | MP0003646_muscle_fatigue | 3.24676547 |
| 8 | MP0008058_abnormal_DNA_repair | 3.21510046 |
| 9 | MP0003123_paternal_imprinting | 3.18108894 |
| 10 | MP0008932_abnormal_embryonic_tissue | 3.02298356 |
| 11 | MP0008877_abnormal_DNA_methylation | 2.92590624 |
| 12 | MP0002102_abnormal_ear_morphology | 2.90790093 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.74071674 |
| 14 | MP0002653_abnormal_ependyma_morphology | 2.53865542 |
| 15 | MP0008057_abnormal_DNA_replication | 2.44371566 |
| 16 | MP0006292_abnormal_olfactory_placode | 2.26998626 |
| 17 | MP0005451_abnormal_body_composition | 2.24363958 |
| 18 | MP0003786_premature_aging | 2.17383706 |
| 19 | MP0001730_embryonic_growth_arrest | 2.10248336 |
| 20 | MP0000350_abnormal_cell_proliferation | 1.90794147 |
| 21 | MP0001661_extended_life_span | 1.88007955 |
| 22 | MP0003303_peritoneal_inflammation | 1.76871904 |
| 23 | MP0009672_abnormal_birth_weight | 1.75321782 |
| 24 | MP0003315_abnormal_perineum_morphology | 1.68888360 |
| 25 | MP0001529_abnormal_vocalization | 1.66817514 |
| 26 | MP0001697_abnormal_embryo_size | 1.64531746 |
| 27 | MP0010030_abnormal_orbit_morphology | 1.61711520 |
| 28 | MP0002210_abnormal_sex_determination | 1.58541481 |
| 29 | MP0003121_genomic_imprinting | 1.57147339 |
| 30 | MP0000467_abnormal_esophagus_morphology | 1.52377411 |
| 31 | MP0001293_anophthalmia | 1.47988661 |
| 32 | MP0003941_abnormal_skin_development | 1.47516984 |
| 33 | MP0001915_intracranial_hemorrhage | 1.45669850 |
| 34 | MP0002085_abnormal_embryonic_tissue | 1.45341765 |
| 35 | MP0001672_abnormal_embryogenesis/_devel | 1.44439893 |
| 36 | MP0005380_embryogenesis_phenotype | 1.44439893 |
| 37 | MP0001119_abnormal_female_reproductive | 1.39363581 |
| 38 | MP0000653_abnormal_sex_gland | 1.38729910 |
| 39 | MP0001929_abnormal_gametogenesis | 1.38176056 |
| 40 | MP0005501_abnormal_skin_physiology | 1.36733805 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.36629513 |
| 42 | MP0002080_prenatal_lethality | 1.35170927 |
| 43 | MP0000490_abnormal_crypts_of | 1.34754958 |
| 44 | MP0009697_abnormal_copulation | 1.30678622 |
| 45 | MP0001145_abnormal_male_reproductive | 1.30269591 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.25813931 |
| 47 | MP0003984_embryonic_growth_retardation | 1.24766050 |
| 48 | MP0000313_abnormal_cell_death | 1.19910421 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.19630285 |
| 50 | MP0003186_abnormal_redox_activity | 1.18665032 |
| 51 | MP0002084_abnormal_developmental_patter | 1.18490205 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.18473698 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.15393490 |
| 54 | MP0008260_abnormal_autophagy | 1.14502748 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.14016930 |
| 56 | MP0009840_abnormal_foam_cell | 1.13397403 |
| 57 | MP0004133_heterotaxia | 1.12319487 |
| 58 | MP0003937_abnormal_limbs/digits/tail_de | 1.10952255 |
| 59 | MP0005395_other_phenotype | 1.09765360 |
| 60 | MP0005332_abnormal_amino_acid | 1.08229897 |
| 61 | MP0002160_abnormal_reproductive_system | 1.08050944 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.08035735 |
| 63 | MP0003699_abnormal_female_reproductive | 1.00369468 |
| 64 | MP0000372_irregular_coat_pigmentation | 1.00027654 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 0.98730347 |
| 66 | MP0000358_abnormal_cell_content/ | 0.97994475 |
| 67 | MP0002249_abnormal_larynx_morphology | 0.97457607 |
| 68 | MP0002396_abnormal_hematopoietic_system | 0.97281595 |
| 69 | MP0001849_ear_inflammation | 0.97105045 |
| 70 | MP0001905_abnormal_dopamine_level | 0.95807180 |
| 71 | MP0005379_endocrine/exocrine_gland_phen | 0.95104705 |
| 72 | MP0003115_abnormal_respiratory_system | 0.94051662 |
| 73 | MP0002163_abnormal_gland_morphology | 0.93801938 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 0.91992409 |
| 75 | MP0005408_hypopigmentation | 0.90137003 |
| 76 | MP0005330_cardiomyopathy | 0.88626381 |
| 77 | MP0005389_reproductive_system_phenotype | 0.88141821 |
| 78 | MP0000428_abnormal_craniofacial_morphol | 0.87735270 |
| 79 | MP0002697_abnormal_eye_size | 0.87576350 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 0.85818830 |
| 81 | MP0002876_abnormal_thyroid_physiology | 0.85576204 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 0.85437240 |
| 83 | MP0003890_abnormal_embryonic-extraembry | 0.85145304 |
| 84 | MP0002086_abnormal_extraembryonic_tissu | 0.85116032 |
| 85 | MP0003119_abnormal_digestive_system | 0.85110614 |
| 86 | MP0001881_abnormal_mammary_gland | 0.84767999 |
| 87 | MP0001286_abnormal_eye_development | 0.83071934 |
| 88 | MP0008995_early_reproductive_senescence | 0.81159553 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.80964632 |
| 90 | MP0003942_abnormal_urinary_system | 0.80711542 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.79741889 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.78924517 |
| 93 | MP0002092_abnormal_eye_morphology | 0.77932148 |
| 94 | MP0002161_abnormal_fertility/fecundity | 0.75772666 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.74016072 |
| 96 | MP0010307_abnormal_tumor_latency | 0.73559305 |
| 97 | MP0002127_abnormal_cardiovascular_syste | 0.73265834 |
| 98 | MP0002132_abnormal_respiratory_system | 0.72995339 |
| 99 | MP0005384_cellular_phenotype | 0.72244684 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.72085417 |
| 101 | MP0000477_abnormal_intestine_morphology | 0.71645395 |
| 102 | MP0005266_abnormal_metabolism | 0.71060693 |
| 103 | MP0001727_abnormal_embryo_implantation | 0.69073494 |
| 104 | MP0009053_abnormal_anal_canal | 0.68395259 |
| 105 | MP0002751_abnormal_autonomic_nervous | 0.68346965 |
| 106 | MP0001919_abnormal_reproductive_system | 0.67483122 |
| 107 | MP0004084_abnormal_cardiac_muscle | 0.67115762 |
| 108 | MP0005257_abnormal_intraocular_pressure | 0.67071098 |
| 109 | MP0005360_urolithiasis | 0.66852870 |
| 110 | MP0004145_abnormal_muscle_electrophysio | 0.66339755 |
| 111 | MP0003698_abnormal_male_reproductive | 0.66255646 |
| 112 | MP0003787_abnormal_imprinting | 0.65502655 |
| 113 | MP0000049_abnormal_middle_ear | 0.65383656 |
| 114 | MP0000566_synostosis | 0.64651119 |
| 115 | MP0004019_abnormal_vitamin_homeostasis | 0.63982422 |
| 116 | MP0003938_abnormal_ear_development | 0.63166219 |
| 117 | MP0006072_abnormal_retinal_apoptosis | 0.62120007 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.61982138 |
| 119 | MP0005621_abnormal_cell_physiology | 0.61616225 |
| 120 | MP0006082_CNS_inflammation | 0.61501615 |
| 121 | MP0001764_abnormal_homeostasis | 0.61321739 |
| 122 | MP0002111_abnormal_tail_morphology | 0.59650291 |
| 123 | MP0001664_abnormal_digestion | 0.59564100 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.59526749 |
| 125 | MP0008875_abnormal_xenobiotic_pharmacok | 0.58864497 |
| 126 | MP0000598_abnormal_liver_morphology | 0.58481280 |
| 127 | MP0005083_abnormal_biliary_tract | 0.56862426 |
| 128 | MP0005636_abnormal_mineral_homeostasis | 0.56501540 |
| 129 | MP0004197_abnormal_fetal_growth/weight/ | 0.55589887 |
| 130 | MP0002938_white_spotting | 0.54869450 |
| 131 | MP0003656_abnormal_erythrocyte_physiolo | 0.54482800 |
| 132 | MP0002114_abnormal_axial_skeleton | 0.54265267 |
| 133 | MP0003136_yellow_coat_color | 0.54242480 |
| 134 | MP0003755_abnormal_palate_morphology | 0.53999871 |
| 135 | MP0009379_abnormal_foot_pigmentation | 0.53897302 |
| 136 | MP0004233_abnormal_muscle_weight | 0.53150318 |
| 137 | MP0003763_abnormal_thymus_physiology | 0.52716756 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.52274051 |
| 139 | MP0005499_abnormal_olfactory_system | 0.50906634 |
| 140 | MP0005394_taste/olfaction_phenotype | 0.50906634 |
| 141 | MP0002269_muscular_atrophy | 0.50899399 |
| 142 | MP0000703_abnormal_thymus_morphology | 0.50330594 |
| 143 | MP0004215_abnormal_myocardial_fiber | 0.48836241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive muscle weakness (HP:0003323) | 6.08198421 |
| 2 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 6.00569394 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 5.72934713 |
| 4 | Breast hypoplasia (HP:0003187) | 5.17804073 |
| 5 | Cerebral hypomyelination (HP:0006808) | 4.06211114 |
| 6 | Patellar aplasia (HP:0006443) | 4.02520288 |
| 7 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.80568260 |
| 8 | Acute necrotizing encephalopathy (HP:0006965) | 3.73184690 |
| 9 | Carpal bone hypoplasia (HP:0001498) | 3.61648420 |
| 10 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.55996022 |
| 11 | Long foot (HP:0001833) | 3.45734019 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.42856477 |
| 13 | Mitochondrial inheritance (HP:0001427) | 3.39692302 |
| 14 | Hepatocellular necrosis (HP:0001404) | 3.35246992 |
| 15 | Abnormality of the labia minora (HP:0012880) | 3.28165845 |
| 16 | Chromsome breakage (HP:0040012) | 3.27450578 |
| 17 | Increased CSF lactate (HP:0002490) | 3.22849543 |
| 18 | Oral leukoplakia (HP:0002745) | 3.18675532 |
| 19 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.15729662 |
| 20 | Type I transferrin isoform profile (HP:0003642) | 3.15347744 |
| 21 | Secondary amenorrhea (HP:0000869) | 3.09003939 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.08164074 |
| 23 | Increased serum pyruvate (HP:0003542) | 3.08164074 |
| 24 | Reticulocytopenia (HP:0001896) | 3.08135083 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.05405764 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.05405764 |
| 27 | Duplicated collecting system (HP:0000081) | 2.98735253 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.98368696 |
| 29 | Acute encephalopathy (HP:0006846) | 2.97118086 |
| 30 | Abnormality of the preputium (HP:0100587) | 2.97045921 |
| 31 | Meckel diverticulum (HP:0002245) | 2.92559538 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.92380359 |
| 33 | Rhabdomyolysis (HP:0003201) | 2.91270911 |
| 34 | Aplastic anemia (HP:0001915) | 2.90614136 |
| 35 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.90428435 |
| 36 | Microvesicular hepatic steatosis (HP:0001414) | 2.86608584 |
| 37 | Progressive macrocephaly (HP:0004481) | 2.82677461 |
| 38 | Hepatic necrosis (HP:0002605) | 2.80685365 |
| 39 | Premature ovarian failure (HP:0008209) | 2.79221577 |
| 40 | Abnormality of the ileum (HP:0001549) | 2.77985400 |
| 41 | Large for gestational age (HP:0001520) | 2.77642225 |
| 42 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.75760029 |
| 43 | Myoglobinuria (HP:0002913) | 2.75474626 |
| 44 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.74111979 |
| 45 | Dry hair (HP:0011359) | 2.73967229 |
| 46 | Abnormal number of erythroid precursors (HP:0012131) | 2.73405548 |
| 47 | Hypoplastic pelvis (HP:0008839) | 2.72838499 |
| 48 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.72602494 |
| 49 | Ragged-red muscle fibers (HP:0003200) | 2.72058770 |
| 50 | Increased serum lactate (HP:0002151) | 2.71162918 |
| 51 | Absent radius (HP:0003974) | 2.69740743 |
| 52 | Exertional dyspnea (HP:0002875) | 2.66923842 |
| 53 | Microretrognathia (HP:0000308) | 2.65847050 |
| 54 | Flat capital femoral epiphysis (HP:0003370) | 2.63466465 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.63284002 |
| 56 | Abnormality of chromosome stability (HP:0003220) | 2.62142106 |
| 57 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.61899028 |
| 58 | Abnormal glycosylation (HP:0012345) | 2.60040733 |
| 59 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.60040733 |
| 60 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.60040733 |
| 61 | Abnormal protein glycosylation (HP:0012346) | 2.60040733 |
| 62 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.59613522 |
| 63 | Abnormality of alanine metabolism (HP:0010916) | 2.59613522 |
| 64 | Hyperalaninemia (HP:0003348) | 2.59613522 |
| 65 | Hypobetalipoproteinemia (HP:0003563) | 2.55978859 |
| 66 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.55355319 |
| 67 | Absent forearm bone (HP:0003953) | 2.53413177 |
| 68 | Aplasia involving forearm bones (HP:0009822) | 2.53413177 |
| 69 | Generalized amyotrophy (HP:0003700) | 2.52723436 |
| 70 | Degeneration of anterior horn cells (HP:0002398) | 2.52208723 |
| 71 | Abnormality of the anterior horn cell (HP:0006802) | 2.52208723 |
| 72 | Irregular epiphyses (HP:0010582) | 2.47658294 |
| 73 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.47517175 |
| 74 | Adrenal hypoplasia (HP:0000835) | 2.47426290 |
| 75 | Lipid accumulation in hepatocytes (HP:0006561) | 2.47241678 |
| 76 | Ureteral duplication (HP:0000073) | 2.44915905 |
| 77 | Supernumerary spleens (HP:0009799) | 2.44337536 |
| 78 | Horseshoe kidney (HP:0000085) | 2.42324800 |
| 79 | Epiphyseal stippling (HP:0010655) | 2.41086275 |
| 80 | Cerebral edema (HP:0002181) | 2.40577699 |
| 81 | Breast aplasia (HP:0100783) | 2.37908667 |
| 82 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.37837800 |
| 83 | CNS hypomyelination (HP:0003429) | 2.36924275 |
| 84 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 2.36412508 |
| 85 | Respiratory difficulties (HP:0002880) | 2.35941240 |
| 86 | Exercise intolerance (HP:0003546) | 2.35098332 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.34999857 |
| 88 | Cholecystitis (HP:0001082) | 2.34999857 |
| 89 | Brushfield spots (HP:0001088) | 2.34293921 |
| 90 | Small intestinal stenosis (HP:0012848) | 2.33092715 |
| 91 | Duodenal stenosis (HP:0100867) | 2.33092715 |
| 92 | Abnormality of the renal collecting system (HP:0004742) | 2.32161728 |
| 93 | Steatorrhea (HP:0002570) | 2.32049761 |
| 94 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.29853931 |
| 95 | Macrocytic anemia (HP:0001972) | 2.29695905 |
| 96 | Unsteady gait (HP:0002317) | 2.29651141 |
| 97 | Progressive external ophthalmoplegia (HP:0000590) | 2.29619901 |
| 98 | Pancreatic fibrosis (HP:0100732) | 2.29228289 |
| 99 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.28992456 |
| 100 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.28992456 |
| 101 | Hyperammonemia (HP:0001987) | 2.27209974 |
| 102 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.26774874 |
| 103 | Transposition of the great arteries (HP:0001669) | 2.26774874 |
| 104 | Abnormal connection of the cardiac segments (HP:0011545) | 2.26774874 |
| 105 | Triphalangeal thumb (HP:0001199) | 2.22157611 |
| 106 | Severe muscular hypotonia (HP:0006829) | 2.20657055 |
| 107 | Increased muscle lipid content (HP:0009058) | 2.20419668 |
| 108 | Absent thumb (HP:0009777) | 2.19116401 |
| 109 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.18947669 |
| 110 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.18205637 |
| 111 | Abnormality of methionine metabolism (HP:0010901) | 2.17332805 |
| 112 | Type 2 muscle fiber atrophy (HP:0003554) | 2.16845474 |
| 113 | Respiratory failure (HP:0002878) | 2.16047831 |
| 114 | Lactic acidosis (HP:0003128) | 2.15075574 |
| 115 | Muscle fiber atrophy (HP:0100295) | 2.15044032 |
| 116 | Pancreatic cysts (HP:0001737) | 2.13847055 |
| 117 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.13714035 |
| 118 | Myelodysplasia (HP:0002863) | 2.13241863 |
| 119 | Increased intramyocellular lipid droplets (HP:0012240) | 2.13165368 |
| 120 | Abnormal trabecular bone morphology (HP:0100671) | 2.12403696 |
| 121 | Hypoglycemic seizures (HP:0002173) | 2.12175413 |
| 122 | Prolonged partial thromboplastin time (HP:0003645) | 2.11321803 |
| 123 | Bone marrow hypocellularity (HP:0005528) | 2.10946847 |
| 124 | Premature graying of hair (HP:0002216) | 2.10583659 |
| 125 | Male infertility (HP:0003251) | 2.10173385 |
| 126 | Sloping forehead (HP:0000340) | 2.10034673 |
| 127 | Abnormality of the umbilical cord (HP:0010881) | 2.08882426 |
| 128 | Reduced antithrombin III activity (HP:0001976) | 2.08859761 |
| 129 | Squamous cell carcinoma (HP:0002860) | 2.07133820 |
| 130 | Emotional lability (HP:0000712) | 2.05730223 |
| 131 | Slender long bone (HP:0003100) | 2.05399390 |
| 132 | Cleft eyelid (HP:0000625) | 2.05397715 |
| 133 | Multiple enchondromatosis (HP:0005701) | 2.05389654 |
| 134 | 3-Methylglutaconic aciduria (HP:0003535) | 2.05372423 |
| 135 | Acute lymphatic leukemia (HP:0006721) | 2.03122758 |
| 136 | Autoamputation (HP:0001218) | 2.02684011 |
| 137 | Abnormal lung lobation (HP:0002101) | 2.01637110 |
| 138 | CNS demyelination (HP:0007305) | 2.01376411 |
| 139 | Selective tooth agenesis (HP:0001592) | 1.97576672 |
| 140 | Pancytopenia (HP:0001876) | 1.97575315 |
| 141 | Trismus (HP:0000211) | 1.96387136 |
| 142 | Renal Fanconi syndrome (HP:0001994) | 1.95005103 |
| 143 | Postnatal microcephaly (HP:0005484) | 1.92162345 |
| 144 | Pallor (HP:0000980) | 1.92056153 |
| 145 | Sparse eyelashes (HP:0000653) | 1.90303546 |
| 146 | Abnormality of the duodenum (HP:0002246) | 1.89362511 |
| 147 | Neoplasm of the pancreas (HP:0002894) | 1.88983411 |
| 148 | Colon cancer (HP:0003003) | 1.87799046 |
| 149 | Nemaline bodies (HP:0003798) | 1.87220043 |
| 150 | Shawl scrotum (HP:0000049) | 1.86515814 |
| 151 | Testicular atrophy (HP:0000029) | 1.86212331 |
| 152 | Fat malabsorption (HP:0002630) | 1.85309771 |
| 153 | Symptomatic seizures (HP:0011145) | 1.84878757 |
| 154 | Neoplasm of the adrenal gland (HP:0100631) | 1.84830027 |
| 155 | Nausea (HP:0002018) | 1.84557079 |
| 156 | Medulloblastoma (HP:0002885) | 1.84393464 |
| 157 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.84234230 |
| 158 | Single umbilical artery (HP:0001195) | 1.84234230 |
| 159 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.84234230 |
| 160 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.82903359 |
| 161 | Exercise-induced muscle cramps (HP:0003710) | 1.79735585 |
| 162 | Hypokinesia (HP:0002375) | 1.79220093 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.17621028 |
| 2 | PLK4 | 3.59291802 |
| 3 | CDC7 | 3.40799223 |
| 4 | TAOK2 | 3.39532909 |
| 5 | EIF2AK1 | 3.38929775 |
| 6 | WEE1 | 3.27421049 |
| 7 | MAP3K3 | 2.87462121 |
| 8 | BRAF | 2.73481705 |
| 9 | MAP2K3 | 2.60644805 |
| 10 | TTK | 2.57438163 |
| 11 | ARAF | 2.50307274 |
| 12 | STK38L | 2.29204269 |
| 13 | ACVR1B | 2.17763010 |
| 14 | SRPK1 | 2.12350807 |
| 15 | STK16 | 2.10964811 |
| 16 | NEK2 | 2.08363814 |
| 17 | NME2 | 2.03881789 |
| 18 | PDK2 | 2.02250304 |
| 19 | PLK1 | 1.97576736 |
| 20 | VRK1 | 1.92017202 |
| 21 | TLK1 | 1.92004326 |
| 22 | TSSK6 | 1.89390188 |
| 23 | LATS2 | 1.89033583 |
| 24 | CDK8 | 1.88589642 |
| 25 | DYRK2 | 1.80528191 |
| 26 | NEK1 | 1.80158911 |
| 27 | VRK2 | 1.77951085 |
| 28 | TESK2 | 1.67032101 |
| 29 | BRSK2 | 1.65095130 |
| 30 | SMG1 | 1.59134521 |
| 31 | IRAK3 | 1.57205844 |
| 32 | PLK3 | 1.55946975 |
| 33 | MST4 | 1.48840129 |
| 34 | MUSK | 1.47319348 |
| 35 | RAF1 | 1.47073988 |
| 36 | EIF2AK3 | 1.46895408 |
| 37 | AURKB | 1.46120703 |
| 38 | MOS | 1.45530097 |
| 39 | AURKA | 1.42028774 |
| 40 | CHEK2 | 1.39868075 |
| 41 | MAPKAPK3 | 1.34502293 |
| 42 | MAP3K6 | 1.32771956 |
| 43 | CCNB1 | 1.32430547 |
| 44 | BRSK1 | 1.28973606 |
| 45 | DYRK3 | 1.27907496 |
| 46 | MKNK2 | 1.26619810 |
| 47 | CDK7 | 1.15311240 |
| 48 | BMPR2 | 1.14810340 |
| 49 | MKNK1 | 1.07882717 |
| 50 | NME1 | 1.04960431 |
| 51 | MAP3K8 | 1.03198626 |
| 52 | ERBB4 | 1.02269982 |
| 53 | ATR | 0.99729178 |
| 54 | RPS6KB2 | 0.96470909 |
| 55 | KSR2 | 0.91861847 |
| 56 | RPS6KA4 | 0.86829189 |
| 57 | JAK3 | 0.86104292 |
| 58 | PIM2 | 0.85756386 |
| 59 | ABL2 | 0.83518181 |
| 60 | PBK | 0.81599076 |
| 61 | MAP3K12 | 0.80311101 |
| 62 | PRKCI | 0.79410733 |
| 63 | ALK | 0.77186869 |
| 64 | EEF2K | 0.77087147 |
| 65 | AKT3 | 0.76710230 |
| 66 | CHEK1 | 0.76001842 |
| 67 | PAK1 | 0.74619282 |
| 68 | MAP3K9 | 0.71975010 |
| 69 | TAOK1 | 0.70938214 |
| 70 | MELK | 0.69604580 |
| 71 | PASK | 0.69471370 |
| 72 | SCYL2 | 0.69414281 |
| 73 | FGFR4 | 0.69164241 |
| 74 | MAP3K1 | 0.68839772 |
| 75 | ICK | 0.68806186 |
| 76 | TRIM28 | 0.68734794 |
| 77 | ZAK | 0.66826956 |
| 78 | MAP3K11 | 0.60784140 |
| 79 | PAK4 | 0.59488790 |
| 80 | LIMK1 | 0.59436669 |
| 81 | CDK4 | 0.58846046 |
| 82 | CSNK2A1 | 0.57092273 |
| 83 | EPHA2 | 0.57059799 |
| 84 | TAOK3 | 0.56789105 |
| 85 | CDK19 | 0.56763216 |
| 86 | TRIB3 | 0.56032541 |
| 87 | AKT2 | 0.55343258 |
| 88 | BCKDK | 0.54618270 |
| 89 | KDR | 0.53315938 |
| 90 | MST1R | 0.53189490 |
| 91 | ATM | 0.50129637 |
| 92 | LRRK2 | 0.49107433 |
| 93 | CLK1 | 0.48211329 |
| 94 | PLK2 | 0.47878530 |
| 95 | CDK2 | 0.46782232 |
| 96 | MAP2K7 | 0.46673877 |
| 97 | MYLK | 0.43581153 |
| 98 | PDK3 | 0.43520078 |
| 99 | PDK4 | 0.43520078 |
| 100 | CSNK2A2 | 0.43492406 |
| 101 | LATS1 | 0.43076752 |
| 102 | ILK | 0.42543389 |
| 103 | MAP3K5 | 0.42120864 |
| 104 | DAPK1 | 0.41742528 |
| 105 | CDK9 | 0.41533336 |
| 106 | KSR1 | 0.41277683 |
| 107 | DYRK1A | 0.40437419 |
| 108 | MAPK13 | 0.38949684 |
| 109 | STK10 | 0.38423478 |
| 110 | CDK1 | 0.37831468 |
| 111 | STK4 | 0.37819617 |
| 112 | CSNK1G3 | 0.36979501 |
| 113 | EIF2AK2 | 0.36874899 |
| 114 | RPS6KA5 | 0.36541711 |
| 115 | TAF1 | 0.35675457 |
| 116 | MAP2K6 | 0.33715851 |
| 117 | CDK11A | 0.33712559 |
| 118 | CDK18 | 0.32491280 |
| 119 | CDK15 | 0.32329641 |
| 120 | MET | 0.31292277 |
| 121 | TGFBR1 | 0.30549520 |
| 122 | DAPK3 | 0.29577366 |
| 123 | MAPK11 | 0.29116180 |
| 124 | CSNK1E | 0.28214246 |
| 125 | PHKG1 | 0.28020219 |
| 126 | PHKG2 | 0.28020219 |
| 127 | TESK1 | 0.26457789 |
| 128 | CSNK1G1 | 0.26215097 |
| 129 | MAP3K10 | 0.25465695 |
| 130 | OBSCN | 0.25453904 |
| 131 | CDK14 | 0.25122495 |
| 132 | PINK1 | 0.25086148 |
| 133 | FGFR1 | 0.23975513 |
| 134 | TTN | 0.23827491 |
| 135 | PTK2 | 0.23290483 |
| 136 | MAP3K2 | 0.20465589 |
| 137 | FLT3 | 0.20133257 |
| 138 | BMPR1B | 0.18860874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.33443185 |
| 2 | * RNA polymerase_Homo sapiens_hsa03020 | 3.96544958 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.90722929 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.72843015 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 3.44021407 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.40116482 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 3.06402073 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.96226644 |
| 9 | Cell cycle_Homo sapiens_hsa04110 | 2.92093215 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.89749569 |
| 11 | RNA transport_Homo sapiens_hsa03013 | 2.88088111 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.78642099 |
| 13 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.63890389 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 2.62084060 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.45523109 |
| 16 | RNA degradation_Homo sapiens_hsa03018 | 2.39776757 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.20405754 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.15712922 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 1.91433550 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.76470737 |
| 21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.75500873 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75487425 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.73927782 |
| 24 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.66939546 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62740370 |
| 26 | * Purine metabolism_Homo sapiens_hsa00230 | 1.60393230 |
| 27 | Protein export_Homo sapiens_hsa03060 | 1.57900293 |
| 28 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.46871255 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42468957 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40620668 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.37968017 |
| 32 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.29215124 |
| 33 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.27529506 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25298680 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14255181 |
| 36 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13533168 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13164299 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08230206 |
| 39 | Alzheimers disease_Homo sapiens_hsa05010 | 1.07457186 |
| 40 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.05308824 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04428107 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.03639038 |
| 43 | * Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01782592 |
| 44 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.01531930 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.00494209 |
| 46 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.99121760 |
| 47 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98015155 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93543385 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91298222 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83128484 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82867391 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.82732152 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82226784 |
| 54 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.80393442 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.76401319 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75110482 |
| 57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64815731 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.64541922 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63690208 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63535318 |
| 61 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.61066375 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60972575 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60313070 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58276540 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.57765113 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.56977642 |
| 67 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55143848 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52897179 |
| 69 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52453300 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51217362 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50616944 |
| 72 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50256576 |
| 73 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48565200 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48441793 |
| 75 | Carbon metabolism_Homo sapiens_hsa01200 | 0.48230953 |
| 76 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.47940196 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47264458 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.47247827 |
| 79 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.46951324 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45640032 |
| 81 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44164207 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43018709 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41123341 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40261672 |
| 85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.39496698 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.39054283 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38891787 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38458234 |
| 89 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37302889 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35842775 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.33833228 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.29628338 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26936110 |
| 94 | Bladder cancer_Homo sapiens_hsa05219 | 0.26821726 |
| 95 | Alcoholism_Homo sapiens_hsa05034 | 0.25365216 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.25083398 |
| 97 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.24042756 |
| 98 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23141784 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.22510569 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22248499 |
| 101 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.21953130 |
| 102 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21329580 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.20571960 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.20312604 |
| 105 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.18592747 |
| 106 | Shigellosis_Homo sapiens_hsa05131 | 0.18491501 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.18132227 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.17967570 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17179141 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17177526 |
| 111 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.14257298 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.12859535 |
| 113 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.12049618 |
| 114 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12016077 |
| 115 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.11064224 |
| 116 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.10740777 |
| 117 | Apoptosis_Homo sapiens_hsa04210 | 0.09232156 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.08353781 |
| 119 | Hepatitis B_Homo sapiens_hsa05161 | 0.07929690 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.07702044 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.07412740 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.07270752 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.06770166 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06586787 |
| 125 | Melanoma_Homo sapiens_hsa05218 | 0.06121121 |
| 126 | Tight junction_Homo sapiens_hsa04530 | 0.03930678 |
| 127 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03603696 |
| 128 | Legionellosis_Homo sapiens_hsa05134 | 0.03514216 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01556783 |
| 130 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.01170181 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.00842386 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.00197438 |

